Related references
Note: Only part of the references are listed.Inhibitory Effects of Ursolic Acid on the Stemness and Progression of Human Breast Cancer Cells by Modulating Argonaute-2
Wen-Ling Liao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Prevalence, causes and impact of TP53-loss phenocopying events in human tumors
Bruno Fito-Lopez et al.
BMC BIOLOGY (2023)
BPA exposure enhances the metastatic aggression of ovarian cancer through the ERa/AKT/mTOR/HIF-1 alpha signaling axis
Xin Xie et al.
FOOD AND CHEMICAL TOXICOLOGY (2023)
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
Charlene Waryah et al.
ADVANCED SCIENCE (2023)
Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy
Gexuan Jiang et al.
NANOSCALE HORIZONS (2023)
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
Teizo Yoshimura et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2023)
TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer
Jie-Ning Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Mcl-1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer
Xu Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression
Wentao Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation
Le Shu et al.
ONCOGENE (2022)
RNA-binding protein p54nrb/NONO potentiates nuclear EGFR-mediated tumorigenesis of triple-negative breast cancer
Mengqin Shen et al.
CELL DEATH & DISEASE (2022)
miR-223-3p targets FBXW7 to promote epithelial-mesenchymal transition and metastasis in breast cancer
Yuli Wang et al.
THORACIC CANCER (2022)
Macrophage IL-1β promotes arteriogenesis by autocrine STAT3-and NF-κB-mediated transcription of pro-angiogenic VEGF-A
Chris S. Mantsounga et al.
CELL REPORTS (2022)
Overexpression of hsa_circ_0022742 suppressed hyperglycemia-induced endothelial dysfunction by targeting the miR-503-5p/FBXW7 axis
Siyang Liu et al.
MICROVASCULAR RESEARCH (2022)
SOX4-mediated FBW7 transcriptional upregulation confers Tamoxifen resistance in ER plus breast cancers via GATA3 downregulation
Akshay Sharma et al.
LIFE SCIENCES (2022)
NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties
Ling-Ling Wang et al.
MOLECULAR MEDICINE (2022)
The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
Haoyue Hu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration
Sukhraj Pal Singh Dhami et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
Liangliang Xing et al.
FRONTIERS IN ONCOLOGY (2022)
Association of Pathway Mutations With Survival in Taiwanese Breast Cancers
Po-Sheng Yang et al.
FRONTIERS IN ONCOLOGY (2022)
FBXW7 inactivation induces cellular senescence via accumulation of p53
Longyuan Gong et al.
CELL DEATH & DISEASE (2022)
Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast Cancer
Yang Huo et al.
CANCERS (2022)
The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis
Arwa Aldaalis et al.
FRONTIERS IN ONCOLOGY (2022)
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy
Qi Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy
Mi Jeong Kim et al.
CANCER BIOLOGY & THERAPY (2021)
Repression of FBXW7 by HES5 contributes to inactivation of the TGF-beta signaling pathway and alleviation of endometriosis
Li-Juan Chen et al.
FASEB JOURNAL (2021)
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Ruijuan Du et al.
MOLECULAR CANCER (2021)
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
Xianglan Yi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer
Carmine De Angelis et al.
CLINICAL CANCER RESEARCH (2021)
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma
Takafumi Watanabe et al.
TRANSLATIONAL ONCOLOGY (2021)
RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway
Jianbing Hou et al.
CELL DEATH & DISEASE (2021)
High expression levels of centromere protein A plus upregulation of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway affect chemotherapy response and prognosis in patients with breast cancer
Songbo Zhang et al.
ONCOLOGY LETTERS (2021)
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
Vivek Kumar et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer
Ghada M. Sharif et al.
CANCER RESEARCH (2021)
Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells
Xiao Hu et al.
MOLECULAR CARCINOGENESIS (2021)
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Ni Made Pitri Susanti et al.
MOLECULES (2021)
FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation
Kai T. Richter et al.
CELL DEATH AND DIFFERENTIATION (2020)
Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
Takaaki Masuda et al.
CANCER SCIENCE (2020)
Emerging roles of F-box proteins in cancer drug resistance
Linzhi Yan et al.
DRUG RESISTANCE UPDATES (2020)
Decreased expression of FBXW7 by ERK1/2 activation in drug-resistant cancer cells confers transcriptional activation of MDR1 by suppression of ubiquitin degradation of HSF1
Gil-Im Mun et al.
CELL DEATH & DISEASE (2020)
Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade
Cecile Gstalder et al.
CANCER DISCOVERY (2020)
Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells
Maria Giulia Manzione et al.
MOLECULAR BIOLOGY OF THE CELL (2020)
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling
Snahlata Singh et al.
NATURE CELL BIOLOGY (2020)
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Amer M. Zeidan et al.
CLINICAL CANCER RESEARCH (2020)
KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis
Haishan Lin et al.
FRONTIERS IN ONCOLOGY (2020)
Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7
Xingping Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland
Ichiro Onoyama et al.
CANCER RESEARCH (2020)
Environmental chemicals, breast cancer progression and drug resistance
Meriem Koual et al.
ENVIRONMENTAL HEALTH (2020)
Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation
Alison E. Meyer et al.
NEOPLASIA (2020)
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
Kuppusamy Balamurugan et al.
ONCOGENE (2019)
Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology
Gabriele Di Sante et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity
Huiyin Lan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation
Reyhaneh Salehi-Tabar et al.
MOLECULAR CANCER RESEARCH (2019)
circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
Feng Ye et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells
Hideyuki Shimizu et al.
JCI INSIGHT (2019)
The ubiquitin ligase SCFFBXW7α promotes GATA3 degradation
Nan Song et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
NONO ubiquitination is mediated by FBW7 and GSK3 via a degron lost upon chromosomal rearrangement in cancer
Luigi Alfano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yibing Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yibing Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation
Yu Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells
Jones Gyamfi et al.
SCIENTIFIC REPORTS (2018)
FBXW7: a critical tumor suppressor of human cancers
Chien-Hung Yeh et al.
MOLECULAR CANCER (2018)
FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1
Akiko Mori et al.
CANCER SCIENCE (2018)
Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downreguating MTDH expression
Wuguo Tian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation
X. Chen et al.
NEOPLASMA (2018)
EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer
Jun Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor
Mamoru Takada et al.
ONCOTARGET (2017)
27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator
Sisi He et al.
MATURITAS (2017)
MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells
J. Zhao et al.
ONCOGENE (2017)
The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy
Xiao-qing Ding et al.
ONCOTARGET (2017)
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
Saoirse O. Dolly et al.
BRITISH JOURNAL OF CANCER (2017)
FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A
Mamoru Takada et al.
CANCER RESEARCH (2017)
MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7
Wei Xia et al.
CANCER CELL INTERNATIONAL (2017)
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Ende Zhao et al.
NATURE IMMUNOLOGY (2016)
NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function
F. Sun et al.
ONCOGENE (2016)
MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity
J. Xue et al.
ONCOGENE (2016)
27-Hydroxycholesterol increases Myc protein stability via suppressing PP2A, SCP1 and FBW7 transcription in MCF-7 breast cancer cells
Li-Ming Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma
Federico Rojo et al.
BRITISH JOURNAL OF CANCER (2016)
Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1
Eun-Jung Ann et al.
CANCER RESEARCH (2016)
The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer
D. Mendoza-Villanueva et al.
ONCOGENE (2016)
F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check
Victor M. Diaz et al.
SEMINARS IN CANCER BIOLOGY (2016)
Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
Weiguo Zhang et al.
NATURE COMMUNICATIONS (2016)
Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
Jessica Gasca et al.
ONCOTARGET (2016)
Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse
A. D. Hartkopf et al.
ANNALS OF ONCOLOGY (2015)
Anti-proliferative effects of gamma-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells
P. Parajuli et al.
CELL PROLIFERATION (2015)
F-box protein FBXW7 inhibits-cancer metastasis in a non-cell-autonomous manner
Kanae Yumimoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc
Xiao-Xin Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Regulation of circRNA biogenesis
Ling-Ling Chen et al.
RNA BIOLOGY (2015)
Fbxw7 suppresses cancer metastasis by inhibiting niche formation
Kanae Yumimoto et al.
ONCOIMMUNOLOGY (2015)
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
Alessandra Rustighi et al.
EMBO MOLECULAR MEDICINE (2014)
Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines
Hayley Davis et al.
GUT (2014)
CaMKIV-Dependent Preservation of mTOR Expression Is Required for Autophagy during Lipopolysaccharide-Induced Inflammation and Acute Kidney Injury
Xianghong Zhang et al.
JOURNAL OF IMMUNOLOGY (2014)
The Canonical Wnt Signal Restricts the Glycogen Synthase Kinase 3/Fbw7-Dependent Ubiquitination and Degradation of Eya1 Phosphatase
Ye Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Chromosome Instability Underlies Hematopoietic Stem Cell Dysfunction and Lymphoid Neoplasia Associated with Impaired Fbw7-Mediated Cyclin E Regulation
Ka Tat Siu et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Jessica A. Gasser et al.
MOLECULAR CELL (2014)
CSN6 drives carcinogenesis by positively regulating Myc stability
Jian Chen et al.
NATURE COMMUNICATIONS (2014)
Dual Regulation of Fbw7 Function and Oncogenic Transformation by Usp28
Christina Schuelein-Voelk et al.
CELL REPORTS (2014)
Ablation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence
Shoichiro Takeishi et al.
CANCER CELL (2013)
Fbw7 dimerization determines the specificity and robustness of substrate degradation
Markus Welcker et al.
GENES & DEVELOPMENT (2013)
PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha
Chunhua Yang et al.
MOLECULAR CANCER (2013)
FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4
Kuppusamy Balamurugan et al.
NATURE COMMUNICATIONS (2013)
FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7
Zeran Wang et al.
ONCOTARGET (2013)
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
Ernestina Marianna De Francesco et al.
BREAST CANCER RESEARCH (2013)
J-4: a novel and typical preclinical anticancer drug targeting protein kinase C ζ
Hongyan Li et al.
ANTI-CANCER DRUGS (2012)
GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α
Daniela Flugel et al.
BLOOD (2012)
Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4)
Onur Cizmecioglu et al.
JOURNAL OF CELL SCIENCE (2012)
Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer
Yueyong Liu et al.
PLOS ONE (2012)
SCFFbw7 Modulates the NFκB Signaling Pathway by Targeting NFκB2 for Ubiquitination and Destruction
Hidefumi Fukushima et al.
CELL REPORTS (2012)
Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
Mutsuko Ibusuki et al.
CANCER SCIENCE (2011)
MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
Mikael Lerner et al.
CELL CYCLE (2011)
PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity
Christina Schuelein et al.
FEBS LETTERS (2011)
Regulation of the tumour suppressor Fbw7α by PKC-dependent phosphorylation and cancer-associated mutations
Joanne Durgan et al.
BIOCHEMICAL JOURNAL (2010)
The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis
Kuppusamy Balamurugan et al.
EMBO JOURNAL (2010)
Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-delta gene in hepatocytes
Saira Ali et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Metabolic control of G1-S transition: cyclin E degradation by p53-induced activation of the ubiquitin-proteasome system
Sudip Mandal et al.
JOURNAL OF CELL BIOLOGY (2010)
Inactivation of FBXW7/hCDC4-beta expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer
Shahab Akhoondi et al.
BREAST CANCER RESEARCH (2010)
NUMB controls p53 tumour suppressor activity
Ivan N. Colaluca et al.
NATURE (2008)
Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy
S. Finkin et al.
ONCOGENE (2008)
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
Jian-Hua Mao et al.
SCIENCE (2008)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Benjamin J. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination
Xiaojing Tang et al.
CELL (2007)
Promoter methylation reduces C/EBP delta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors
D Tang et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Functional interaction of 13 yeast SCF complexes with a set of yeast E2 enzymes in vitro
BM Kus et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation
M Welcker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint
CL Rieder et al.
DEVELOPMENTAL CELL (2004)
A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size
M Welcker et al.
CURRENT BIOLOGY (2004)
hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53
T Kimura et al.
CANCER SCIENCE (2003)
Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line
H Strohmaier et al.
NATURE (2001)
Share Paper
